Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2025-12-24 @ 10:29 PM
NCT ID:
NCT01176435
Eligibility Criteria:
Inclusion Criteria:
* Age 3 to 60 years with albinism
Exclusion Criteria:
* Glaucoma or at increased risk of glaucoma
* History of dystonia
* History of melanoma
* Planning to undergo eye muscle surgery during study time frame
* Undergoing vision therapy
* Taking iron supplements or vitamins with iron
* Taking medication for ADHD
* Known liver or gastrointestinal disease
* Previous treatment with levodopa
* Psychological problems
* Ocular abnormalities other than those associated with albinism
* Pregnant, nursing or planning to become pregnant during study
* Known allergy to levodopa/carbidopa
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
60 Years
Study:
NCT01176435
Study Brief:
Protocol Section:
NCT01176435